SCHEMBL6257529

SCHEMBL6257529

CCC(=O)c1ccc(OCC(O)CNC(=O)NCCc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
MAPT P10636 3/20 0.58
NPSR1 Q6W5P4 2/20 0.58
ALDH1A1 P00352 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
ABCB1 P08183 6/20 0.55
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
CA12 O43570 3/20 0.51
CA1 P00915 3/20 0.51
CA2 P00918 3/20 0.51
CA9 Q16790 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6260126 0.89 ABCB1 (0.59) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL6322809 0.87 ADRB1 (0.61) MEN1KMT2AALDH1A1ABCB1CA12
SCHEMBL6258143 0.86 CASR (0.58) MEN1KMT2AMAPTALDH1A1ABCB1
SCHEMBL6255751 0.84 MEN1 (0.61) MEN1KMT2AMAPTABCB1NPC1
SCHEMBL6255835 0.84 ABCB1 (0.56) MEN1KMT2AMAPTALDH1A1ABCB1
SCHEMBL6260399 0.83 ADRB1 (0.64) MEN1KMT2AMAPTALDH1A1CYP1A2
SCHEMBL6259862 0.82 ABCB1 (0.58) MAPTALDH1A1ABCB1CA12CA1
SCHEMBL6256734 0.81 MEN1 (0.58) MEN1KMT2AMAPTNPSR1ABCB1
SCHEMBL6258812 0.81 MAPT (0.62) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL6260086 0.79 KDM4E (0.57) KMT2AMAPTALDH1A1ABCB1ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962945-B2 N-aryloxypropanolyl-N′-phenethyl-urea COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-11-08 US claimed
US-20050215631-A1 NOVEL N-ARYLOXYPROPANOLYL-N' - PHENETHYL - UREA COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-09-29 US claimed
WO-2005063699-A1 N-ARYLOXYPROPANOLYL-N’-PHENETHYL-UREA COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2005-07-14 WO claimed
US-6962945-B2 N-aryloxypropanolyl-N′-phenethyl-urea COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-11-08 US disclosed
US-20050215631-A1 NOVEL N-ARYLOXYPROPANOLYL-N' - PHENETHYL - UREA COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-09-29 US disclosed
WO-2005063699-A1 N-ARYLOXYPROPANOLYL-N’-PHENETHYL-UREA COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2005-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215631-A1 NOVEL N-ARYLOXYPROPANOLYL-N' - PHENETHYL - UREA NPY4R, GPR119, MC4R MEN1 3594/4885KMT2A 1285/4885MAPT 4471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.